top of page

All speakers

1E9 had a lot of speakers since 2019. You can browse through them here.

Neue Medikamente gegen Übergewicht. Experte dafür:

Matthias Tschöp

CEO, Helmholtz Munich; VP, Helmholtz Association; Alexander von Humboldt Professor, Technical University of Munich

Helmholtz Munich

Matthias Tschöp is the CEO of Helmholtz Munich, Vice President of the German Helmholtz Association and Alexander-von-Humboldt Professor at the Technical University of Munich. Tschöp unraveled fundamental gut-brain signals to discover the first highly effective drugs for human obesity in collaboration with the chemist Richard DiMarchi - the dual and triple gut hormone multi-agonists. A first representative is FDA-approved, others are successfully progressing through clinical trials. Tschöp has received numerous honors and awards, including the Banting Medal (2023), the Heinrich Wieland Prize (2023), the Schering Prize (2023), the EASD-Lilly Centennial Prize (2022) and the Ernst Jung Prize (2021). He holds an adjunct professorship at Yale University and an honorary doctorate at Leipzig University. He was elected a member of the German, Bavarian, and European Academies of Sciences, the American Society for Clinical Investigation and the Association of American Physicians.

Sessions (TBD)

Speaker at 1E9 Events

Festival der Zukunft 2024

Festival der Zukunft 2024

Matthias Tschöp
bottom of page